Hepatitis C viral infection in the immunosuppressed patient (Q41679117)

7 October 2017

1 reference

title

Hepatitis C viral infection in the immunosuppressed patient (English)

1 reference

7 October 2017

1 reference

Collier J

1

1 reference

PubMed ID

9425909

7 October 2017

Heathcote J

series ordinal

2

1 reference

PubMed ID

9425909

7 October 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

7 October 2017

1 reference

7 October 2017

27

1 reference

7 October 2017

2-6

1 reference

7 October 2017

1

1 reference

Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin

7 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

The natural history of chronic hepatitis C in haemophiliacs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Transmission of hepatitis C virus by organ transplantation in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Hepatitis C viral infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Quantitation of hepatitis C virus RNA in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Retransplantation for recurrent hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270102

7 January 2021

Identifiers

DOI

10.1002/HEP.510270102

1 reference

7 October 2017

1 reference

PubMed ID

9425909